Far-fetched fictional pharma trial anchors new Netflix series ‘Maniac’

Neberdine Pharmaceutical and Biotech’s latest clinical trial is billed as a three-day treatment that can cure the brain of any mental dysfunction. Sound too good to be true? That’s because it is. The fictional pharma company and its made-up miracle drug is at the center of a new Netflix series set to debut Sept. 21.